Podcast: Can Low-Dose Immunotherapy Expand Global Access to Cancer Care?
Abstract
Dr. Monty Pal and Dr. Atul Batra discuss the PLANeT study from India, which evaluated low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer, and its place among a growing body of international research on improving efficacy while reducing costs and toxicity with lower doses of immunotherapy.
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Breast Cancer Treatment Studies
Cutaneous Melanoma Detection and Management
Publication details
- Journal / source
- Default Digital Object Group
- Publication date
- 5 February 2026
- Document type
- Dataset